Glucose control in severely thermally injured pediatric patients: what glucose range should be the target?

Marc G Jeschke1, Robert Kraft, Fatemeh Emdad

  • 1Shriners Hospitals for Children, Biochemistry and Molecular Biology, Galveston, TX, USA. majeschk@utmb.edu

Annals of Surgery
|August 27, 2010
PubMed

Insights

Targeting a blood glucose level of 130 mg/dL in severely burned pediatric patients is associated with improved outcomes. This glucose range reduces infections, sepsis, and mortality, while attenuating inflammatory responses.

Area of Science:

  • Critical care medicine
  • Pediatric burn management
  • Metabolic control in trauma

Background:

  • Tight glycemic control in intensive care units has shown detrimental outcomes.
  • Evidence suggests current tight euglycemic control protocols may be harmful.
  • No established glucose range is currently recommended for thermally injured patients.

Purpose of the Study:

  • To identify optimal blood glucose levels for improved outcomes in severely burned pediatric patients.
  • To evaluate the association between specific glucose ranges and patient morbidity and mortality.
  • To guide glucose management strategies in critical burn care.

Main Methods:

  • A cohort of 208 severely burned pediatric patients (burns >30% TBSA) was analyzed.
  • Statistical models determined daily average and 6 AM glucose targets linked to outcomes.
  • Patients were stratified into good vs. poor glucose control groups for comparative analysis.

Main Results:

  • Hyperglycemia strongly predicts adverse hospital outcomes.
  • A daily 6 AM glucose level of 130 mg/dL and a daily average of 140 mg/dL correlate with better outcomes.
  • Patients with glucose levels around 130 mg/dL exhibited reduced inflammation, infection, sepsis, and mortality.

Conclusions:

  • A target blood glucose level of 130 mg/dL is suggested for severely burned patients.
  • This target range may mitigate risks associated with hypoglycemia and improve survival.
  • Optimizing glucose control is crucial for managing hypermetabolic and inflammatory responses post-burn.
Abstract

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes: